DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sumatriptan (Sumatriptan) - Maternal Drugs Affecting Foetus - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Maternal Drugs Affecting Foetus (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sumatriptan where reactions include maternal drugs affecting foetus. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Sumatriptan side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: male

Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication



Possible Sumatriptan side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: male

Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Vitamins (01549301)
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25



Possible Sumatriptan side effects in

Reported by a physician from Canada on 2012-04-05

Patient:

Reactions: Foetal Growth Restriction, Hypoglycaemia Neonatal, Maternal Drugs Affecting Foetus, Foetal Exposure During Pregnancy, Hypoglycaemia

Drug(s) suspected as cause:
Pantoprazole

Ondansetron
    Indication: Hyperemesis Gravidarum

Oxazepam

Hydroxyzine
    Dosage: 25mg four times per day
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Dosage: 50mg four times per day
    Indication: Hyperemesis Gravidarum

Metoclopramide
    Indication: Hyperemesis Gravidarum

Cosyntropin

Humulin R

Sumatriptan

Aspirin

Thiamine HCL
    Indication: Hyperemesis Gravidarum

Multi-Vitamins
    Indication: Hyperemesis Gravidarum

Hydromorphone HCL

Insulin Aspart



Possible Sumatriptan side effects in female

Reported by a individual with unspecified qualification from Germany on 2012-04-04

Patient: female, weighing 2.7 kg (5.9 pounds)

Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sumatriptan



Possible Sumatriptan side effects in

Reported by a physician from Germany on 2012-03-30

Patient:

Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sumatriptan



Possible Sumatriptan side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-26

Patient: female, weighing 2.7 kg (5.9 pounds)

Reactions: Maternal Drugs Affecting Foetus, Bradycardia Neonatal, Infantile Apnoeic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sumatriptan

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017